Five Indian Firms Near Record Buyback Dates — How It Fuels Stock Prices and Portfolio Tilt
Five Indian companies are about to hit record share‑buyback dates, boosting their stock prices and drawing investors toward higher‑yield equities.
All Cowlpane coverage tagged share buyback, sourced from global financial publications and updated continuously.
Five Indian companies are about to hit record share‑buyback dates, boosting their stock prices and drawing investors toward higher‑yield equities.
Welspun Living and CMS Info Systems will trade ex‑record date today as they launch Rs 420 cr of share repurchases, signaling possible price support for investors.
Zoom beat Q1 expectations, lifted its full‑year guide and authorized a $1 billion buyback, giving developers fresh capital for AI‑powered video solutions.
Nvidia posted Q1 earnings that beat expectations and announced an $80 billion share repurchase, signaling fresh upside for AI‑linked equities.
Zydus Lifesciences jumps 7% to a new 52‑week high after a 9% profit lift and a Rs 1,100 cr buyback, signaling resilience in Indian pharma.
Dhanuka Agritech launches a ₹70 crore buyback and a ₹2 final dividend, while several U.S. firms declare quarterly payouts ranging from $0.10 to $1.50 per share.
Boston Scientific announced a $1.5B investment in MiRus and a $2B share buyback, while Marathon Petroleum posted a Q1 earnings beat. The moves signal confidence in healthcare and energy sectors.
Gland Pharma shares jumped 11% after reporting a 97% rise in Q4 profit and announcing a ₹20 per share dividend. Meanwhile, Sampo finished a 1.7‑million‑share buyback in week 20.